Country:China>Guangdong>Zhuhai
No.5002 South Nanwan Road,Xiangzhou District
Company:Zhuhai Wumei Technology
Mobile:+86 17707567455
Tell0756-8811069
Nilotinib CAS: *-10-0 MF: C28H22F3N7O MW: 529.52 EINECS: Product Categories: API;Molecular Targeted Antineoplastic;Nucleotides and Nucleosides;Bases & Related Reagents;Intermediates & Fine Chemicals;Nucleotides;Pharmaceuticals;Pharmaceutical intermediate;AMN-107;Cardiovascular APIs;Inhibitors. The treatment drug for the new chronic myelogenous leukemia (CML) Nilotinib is a novel drug for targeted cancer therapy and belongs to tyrosine kinase inhibitors for the treatment of patients of chronic myelogenous leukemia (CML) which is resistant to the Gleevec (imatinib) with an excellent efficacy.
Avoid fraud by meeting all sellers in-person to pay for items. BestB2B.COM does not offer any transaction or payment services.